Insider

Kelly A. Kramer

Director · Gilead Sciences, Inc. (GILD)

sold: $1,761,437

DateTradeSharesAvg. priceValueFiling
November 12, 2026Sale 10b5-1 plan notice filed10,376$169.76$1,761,437SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.